Clinical development of cabazitaxel for the treatment of castration-resistant prostate cancer [0.03%]
卡巴他赛治疗去势抵抗性前列腺癌的临床研究进展
Che-Kai Tsao,Sonia Seng,William K Oh et al.
Che-Kai Tsao et al.
Castration resistant prostate cancer has historically been considered chemotherapy insensitive. However, the approval of estramustine phosphate, mitoxantrone, and docetaxel, over the past few decades, has challenged this notion. Despite the...
Gemcitabine: efficacy in the treatment of advanced stage nonsquamous non-small cell lung cancer [0.03%]
吉西他滨治疗晚期非鳞状非小细胞肺癌的疗效分析
Hidetoshi Hayashi,Takayasu Kurata,Kazuhiko Nakagawa
Hidetoshi Hayashi
Lung cancer is the leading cause of cancer-related death in many countries. Approximately half of the patients with non-small cell lung cancer have advanced disease and systemic chemotherapy, especially platinum-based doublets, is currently...
Marc C Chamberlain
Marc C Chamberlain
Despite advances in upfront therapy, the prognosis in the great majority of patients with glioblastoma (GBM) is poor as almost all recur and result in disease-related death. Glioblastoma are highly vascularized cancers with elevated express...
The role of T lymphocytes in cancer patients undergoing immunotherapy with autologous dendritic cells [0.03%]
自体树突细胞免疫治疗的癌症患者T淋巴细胞的作用研究
Cláudia M Rodrigues,Bruna F Matias,Eddie F C Murta et al.
Cláudia M Rodrigues et al.
Introduction: Cancer stems from mutations in specific genes that induce uncontrolled cell proliferation. Dendritic cells (DCs) are important immunologic cells and play a crucial role in the induction of an antitumour resp...
Rapid Increase of the Serum PSA Level in Response to High-Intensity Focused Ultrasound Therapy may be a Potential Indicator of Biochemical Recurrence of Low- and Intermediate-Risk Prostate Cancer [0.03%]
高强度聚焦超声治疗后血清PSA水平的迅速升高可能是低危和中危前列腺癌生化复发的潜在指标
Teruo Inamoto,Kazumasa Komura,Toshikazu Watsuji et al.
Teruo Inamoto et al.
Objectives: To determine the incidence and magnitude of the rapid increase in the serum PSA (riPSA) level after high-intensity focused ultrasound (HIFU) therapy for prostate cancer, and its correlation with clinical facto...
Joleen M Hubbard,Axel Grothey,Daniel J Sargent
Joleen M Hubbard
The majority of patients with gastrointestinal cancers are over the age of 65. This age group comprises the minority of the patients enrolled in clinical trials, and it is unknown whether older patients achieve similar results as younger pa...
A case of metastatic mucoepidermoid carcinoma complicated by resistant hypercalcemia [0.03%]
一例伴发难治性高钙血症的转移性黏膜表皮样癌病例报告
Muhammad J Popalzai,Nelly Aoun,Walid Baz et al.
Muhammad J Popalzai et al.
Tumors of salivary glands are uncommon and comprise of about 2%-4% of all head and neck tumors. About 75%-80% of these tumors are benign and include pleomorphic adenoma, monomorphic adenoma, oncocytoma, and papillary cystadenoma lymphomatos...
Case Reports
Clinical Medicine Insights. Oncology. 2011:5:83-7. DOI:10.4137/CMO.S5733 2011
Relationship between plasma glucose levels and malignant uterine cervical neoplasias [0.03%]
血浆葡萄糖水平与恶性子宫颈神经病之间的关系
Rosekeila Simões Nomelini,Adriano Souza Lima Neto,Kalebe Alexandre Capuci et al.
Rosekeila Simões Nomelini et al.
Background: There is a direct correlation between glycemic load and the risk of developing many malignant neoplasms. Aims: The aim of t...
Achievement of three year remission with bevacizumab and irinotecan in recurrent glioblastoma multiforme: a case report [0.03%]
贝伐单抗联合伊立替康治疗复发性多形性胶质母细胞瘤1例报告
Abhirami Vivekanandarajah,Balakumar Krishnarasa,Mervat Mourad et al.
Abhirami Vivekanandarajah et al.
A 34-year-old man presented to the hospital with right-sided headache. He was diagnosed with GBM. He underwent resection of the tumor with placement of carmustine impregnated wafers. Then he underwent adjuvant chemotherapy with temozolamide...
Trabectedin: safety and efficacy in the treatment of advanced sarcoma [0.03%]
曲贝替丁治疗晚期软组织肉瘤的安全性与有效性研究进展
Csaba Gajdos,Anthony Elias
Csaba Gajdos
Soft tissue sarcomas (STS) are a rare group of malignancies with multiple different subtypes. Close to half of intermediate or high grade STS develop metastatic disease. Treatment of recurrent/metastatic sarcomas is quite challenging with o...